How fast does Opzelura work?

Many patients report visible improvements within 3–4 days of starting Opzelura. The cream delivers fast-acting relief from itching and redness, and helps skin begin to repair. For eczema, symptom improvements often appear within the first week. For vitiligo, repigmentation may take several weeks, though some patients still notice earlier improvement. Treatment is monitored by a healthcare provider to ensure benefits continue.

Is Opzelura safe for long-term use?

Opzelura is only cleared for short-term and intermittent chronic use, not continuous long-term use. Treatment should stop once symptoms clear. For eczema, re-evaluation is recommended if symptoms persist beyond eight weeks. For vitiligo, improvement should continue up to 24 weeks before reassessment. This usage pattern helps limit risks like infections, low blood cell counts, and other side effects associated with long-term immune pathway suppression.

Does ruxolitinib cream interact with other medications?

Because ruxolitinib cream is applied to the skin and minimally absorbed, systemic drug interactions are unlikely. However, combining it with other JAK inhibitors, biologic medications, or strong immunosuppressants is not recommended, due to overlapping effects on the immune system. Patients should avoid applying it near the eyes, mouth, or genital regions.

How does Opzelura help with eczema?

Opzelura relieves symptoms of eczema, such as itching, redness, and rash, by blocking JAK enzymes in the skin that drive inflammation. Applied directly to flare-up areas, it calms immune activity locally, allowing symptoms to heal. It is used non-continuously: treatment is paused once skin clears to help reduce potential side effects.

How does Opzelura work for vitiligo?

Vitiligo causes skin patches to lose pigment. Opzelura can help by interfering with the inflammatory signals in the skin that inhibit melanocyte pigment production. Used up to 24 weeks, it may help restore skin color in nonsegmental vitiligo. Initial treatment lowers inflammation, while continued use encourages color return to treated patches.

Can Opzelura be used for both vitiligo and eczema at once?

Yes. Opzelura is approved for both atopic dermatitis and nonsegmental vitiligo in individuals aged 12 and over. A provider will guide whether to use it for one condition at a time or both, depending on symptom areas. Use should remain short-term or intermittent, with ongoing monitoring for side effects.

What are JAK inhibitors for skin?

Topical JAK inhibitors, like ruxolitinib cream, block the Janus kinase (JAK) enzymes on the skin that drive inflammation. By reducing these signals locally, they help calm itching, redness, and rash in eczema, or encourage repigmentation in vitiligo. Unlike oral JAK drugs, these creams act mainly where applied, lowering systemic risk.

When might a topical JAK inhibitor be chosen over other skin treatments?

A topical JAK inhibitor may be preferred when standard therapies, like topical steroids or calcineurin inhibitors, don’t fully control symptoms or are unsuitable. They offer rapid relief of itching and inflammation and fewer concerns like skin thinning. They are also suitable for treating vitiligo, where other options may be limited.

Spend $99, get free U.S. shipping*

Tariff now required on U.S. shipments. Learn more »

Tel: 1-866-456-3768 Fax: 1-866-544-8993

Resources

Cart

Home / Online Pharmacy / Opzelura

For visual reference only; actual product may vary

US Name:

Opzelura
Alternative Names:

Opzelura
Active Ingredients:

Ruxolitinib
Brand Manufacturer:

Incyte
Manufacturer Location:

Canada
Click here to view Product Insert
Click here to view Product Insert
Click here to view Product Insert

Opzelura ^*

For visual reference only; actual product may vary

Prescription Required

All third-party products, company names, and logos are trademarks™ or registered® trademarks are and remain the property of their respective holders. Their use does not imply any affiliation with or endorsement by them. All references on this site to third-party trademarks are intended to constitute nominative fair use under applicable trademark laws.

Opzelura can treat mild to moderate atopic dermatitis, often called eczema, when symptoms have not fully improved with other prescription creams, and nonsegmental vitiligo.

Place your order

Opzelura Cream Brand	1.5% 100 Grams	- Opzelura – Brand, Opzelura Cream, 1.5%, 100, Grams, 888888, Incyte, 2703 + 0	Our price: $2,200.00

*Please note all prices are in US dollars

Description
Side Effects
Indications
FAQ
Video

Opzelura (generic name: ruxolitinib) is a topical Janus kinase inhibitor (JAK inhibitor) used on the skin to treat two conditions in people twelve years and older. It helps manage mild to moderate atopic dermatitis, often called eczema, in those whose symptoms have not fully improved with other prescription creams. It is also used for nonsegmental vitiligo, a skin condition that causes loss of color in patches, by promoting the return of skin pigment.

This medication works by blocking JAK1 and JAK2 enzymes involved in inflammation and immune signaling on the skin. By stopping these enzymes, Opzelura reduces itching, redness, and inflammation, helping skin symptoms heal over time. Applied directly to the affected areas, it delivers local anti-inflammatory effects without significantly affecting the rest of the body.

Ruxolitinib is part of the pharmacological class of topical JAK inhibitors, a newer category of skin treatments. Unlike systemic JAK inhibitors taken by mouth, Opzelura delivers targeted therapy, making it suitable for short-term and non-continuous chronic use. Its design focuses on reducing symptoms while minimizing widespread immune impact.

Dosage

It is important to follow the dosage instructions printed on the label of the box. Check with a doctor or pharmacist if there are any doubts regarding the proper dosage and method of application of the cream. Typically, a thin layer is applied twice daily to affected skin areas. Use should be limited to a maximum of 60 g per week and not exceed 20 percent of the body’s surface area (BSA). Treatment continues until rash, itching, and redness improve, but if symptoms persist after eight weeks for eczema or twenty‑four weeks for vitiligo, a healthcare provider should reassess. After symptom clearance, treatment is typically stopped, with use restarted only when new symptoms appear.

Storage

Opzelura cream should be stored in its original packaging at room temperature between 68-77°F (20-25°C). It must be kept tightly sealed, protected from moisture and direct sunlight. Do not refrigerate or freeze.

This text is for informational purposes only. Please consult a doctor or pharmacist before using any medication.

Read the information leaflet that comes with the medication.

Most people who use Opzelura do not experience any adverse side effects. Doctors prescribe this medication because they assess the benefits of such treatment outweigh any likely unwanted effects.

Some of the side effects that have been reported include nasopharyngitis (upper respiratory infection), diarrhea, bronchitis, headache, acne, folliculitis, hives, and application-site itching or redness. These are generally mild and localized to areas of treated skin.

Not all side effects are listed here. If these or other unlisted symptoms persist or worsen, consult a healthcare provider or pharmacist.

Opzelura treats:

Atopic dermatitis (eczema) in individuals aged twelve and older. Patients may experience itching, redness, and rash, and this cream helps reduce those symptoms. Treatment aims to calm flare-ups non-continuously, allowing skin to heal between episodes.
For patients with vitiligo, the cream aids in restoring skin pigment in patches affected by the loss of melanocytes. Treatment is continued for up to 24 weeks, depending on response. Use is limited to short-term or noncontinuous chronic applications, meaning it’s not meant for daily long-term use without breaks.

Opzelura should not be used on eyes, mouth, or genital areas.

Many patients report visible improvements within 3–4 days of starting Opzelura. The cream delivers fast-acting relief from itching and redness, and helps skin begin to repair. For eczema, symptom improvements often appear within the first week. For vitiligo, repigmentation may take several weeks, though some patients still notice earlier improvement. Treatment is monitored by a healthcare provider to ensure benefits continue.
Opzelura is only cleared for short-term and intermittent chronic use, not continuous long-term use. Treatment should stop once symptoms clear. For eczema, re-evaluation is recommended if symptoms persist beyond eight weeks. For vitiligo, improvement should continue up to 24 weeks before reassessment. This usage pattern helps limit risks like infections, low blood cell counts, and other side effects associated with long-term immune pathway suppression.

Getting started with IsraelPharm

Required

Send Your Prescription

Secure Payment

No Hidden Fees

Fast Shipping

Generally 7-10 Business Days

Ordering is
simple and safe.

IsraelPharm has been delivering lost cost prescriptions from Israel for over 15 years worldwide. Daily flights allow us to get your medications dispatched fast! Delivery to the USA is under 10 days and you can track and trace every order.